Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
3.89
USD
|
+0.26%
|
|
-9.53%
|
-3.95%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
242.7
|
413
|
363.9
|
614.1
|
264.6
|
255
|
-
|
Enterprise Value (EV)
1 |
1,261
|
1,403
|
1,040
|
1,315
|
264.6
|
964.1
|
915.2
|
P/E ratio
|
-6.74
x
|
652
x
|
5.44
x
|
-41.7
x
|
-2.58
x
|
-11.4
x
|
24.3
x
|
Yield
|
3.65%
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.14
x
|
0.24
x
|
0.26
x
|
0.36
x
|
0.16
x
|
0.15
x
|
0.14
x
|
EV / Revenue
|
0.71
x
|
0.81
x
|
0.74
x
|
0.77
x
|
0.16
x
|
0.57
x
|
0.52
x
|
EV / EBITDA
|
16.6
x
|
9.17
x
|
3.35
x
|
7.43
x
|
1.9
x
|
5.11
x
|
4.13
x
|
EV / FCF
|
-20.7
x
|
29.7
x
|
7.59
x
|
-
|
-
|
27.5
x
|
8.32
x
|
FCF Yield
|
-4.83%
|
3.37%
|
13.2%
|
-
|
-
|
3.63%
|
12%
|
Price to Book
|
0.36
x
|
0.59
x
|
0.45
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
63,211
|
63,345
|
63,737
|
63,971
|
65,343
|
65,541
|
-
|
Reference price
2 |
3.840
|
6.520
|
5.710
|
9.600
|
4.050
|
3.890
|
3.890
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/23/22
|
2/27/23
|
2/27/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,775
|
1,739
|
1,408
|
1,717
|
1,643
|
1,686
|
1,768
|
EBITDA
1 |
76
|
153
|
310
|
177
|
139
|
188.8
|
221.3
|
EBIT
1 |
-81
|
6
|
-11
|
42
|
-65
|
58.4
|
90.95
|
Operating Margin
|
-4.56%
|
0.35%
|
-0.78%
|
2.45%
|
-3.96%
|
3.46%
|
5.14%
|
Earnings before Tax (EBT)
1 |
-148
|
-46
|
-83
|
-24
|
-132
|
-22.05
|
19.75
|
Net income
1 |
-31
|
1
|
66
|
-15
|
-102
|
-22.3
|
10.3
|
Net margin
|
-1.75%
|
0.06%
|
4.69%
|
-0.87%
|
-6.21%
|
-1.32%
|
0.58%
|
EPS
2 |
-0.5700
|
0.0100
|
1.050
|
-0.2300
|
-1.570
|
-0.3400
|
0.1600
|
Free Cash Flow
1 |
-60.9
|
47.31
|
137
|
-
|
-
|
35
|
110
|
FCF margin
|
-3.43%
|
2.72%
|
9.73%
|
-
|
-
|
2.08%
|
6.22%
|
FCF Conversion (EBITDA)
|
-
|
30.92%
|
44.2%
|
-
|
-
|
18.54%
|
49.7%
|
FCF Conversion (Net income)
|
-
|
4,731.1%
|
207.58%
|
-
|
-
|
-
|
1,067.96%
|
Dividend per Share
|
0.1400
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/23/22
|
2/27/23
|
2/27/24
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
374
|
374
|
352
|
399
|
466
|
500
|
467
|
385
|
369
|
422
|
429.7
|
406.7
|
410
|
439
|
EBITDA
1 |
53
|
27.34
|
20
|
34
|
68
|
55
|
51
|
27
|
24
|
37
|
45.57
|
46.2
|
47.97
|
47.83
|
EBIT
1 |
3
|
-10
|
-16
|
-3
|
29
|
16
|
16
|
-6
|
-12
|
-61
|
15
|
14.7
|
13.1
|
15.6
|
Operating Margin
|
0.8%
|
-2.67%
|
-4.55%
|
-0.75%
|
6.22%
|
3.2%
|
3.43%
|
-1.56%
|
-3.25%
|
-14.45%
|
3.49%
|
3.61%
|
3.2%
|
3.55%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-31
|
-82
|
-5.15
|
-5.55
|
-7.05
|
-4.3
|
Net income
1 |
-
|
-24
|
-25
|
-23
|
30
|
4
|
2
|
-17
|
-25
|
-61
|
-0.6
|
-6
|
-8.2
|
-7.6
|
Net margin
|
-
|
-6.42%
|
-7.1%
|
-5.76%
|
6.44%
|
0.8%
|
0.43%
|
-4.42%
|
-6.78%
|
-14.45%
|
-0.14%
|
-1.48%
|
-2%
|
-1.73%
|
EPS
2 |
-0.0700
|
-0.3800
|
-0.3900
|
-0.3600
|
0.4500
|
0.0500
|
0.0200
|
-0.2600
|
-0.3900
|
-0.9400
|
-0.0100
|
-0.0900
|
-0.1300
|
-0.1200
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/2/21
|
2/23/22
|
5/3/22
|
8/3/22
|
11/1/22
|
2/27/23
|
5/9/23
|
8/8/23
|
11/7/23
|
2/27/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
1,018
|
990
|
676
|
701
|
-
|
709
|
660
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
13.4
x
|
6.472
x
|
2.181
x
|
3.96
x
|
-
|
3.756
x
|
2.983
x
|
Free Cash Flow
1 |
-60.9
|
47.3
|
137
|
-
|
-
|
35
|
110
|
ROE (net income / shareholders' equity)
|
-4.46%
|
-1.74%
|
8.75%
|
-1.83%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
10.80
|
11.00
|
12.80
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
0.7700
|
1.970
|
3.650
|
1.080
|
-
|
-
|
-
|
Capex
1 |
103
|
77.2
|
95
|
138
|
-
|
102
|
122
|
Capex / Sales
|
5.79%
|
4.44%
|
6.75%
|
8.04%
|
-
|
6.03%
|
6.88%
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/23/22
|
2/27/23
|
2/27/24
|
-
|
-
|
Last Close Price
3.89
USD Average target price
5.5
USD Spread / Average Target +41.39% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.95% | 255M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|